Current Research Investigations
The ultimate goal of the Science Program is to support the discovery of improved therapies and a cure.
To achieve this goal, the DMRF is dedicated to stimulating the field of dystonia research and supporting the collaborations and projects necessary to accelerate progress.
The DMRF is also devoted to attracting young, talented investigators who are becoming the next generation of leaders in dystonia research. In many cases, DMRF grant and fellowship awards are intended to help investigators gather enough preliminary data to make them eligible for much larger grants from agencies such as the National Institutes of Health.
The DMRF is proud to announce this year's exciting research projects, some of which are continuing from 2012. Each of these projects is meaningful because it addresses one or more of the core directions necessary to advance the field. These core directions include furthering our fundamental understanding of what dystonia is, uncovering the mechanisms in the nervous system that leads to symptoms, creating models of dystonia to use in experiments, and discovering targets for new and improved therapeutics designed specifically to treat dystonia.
Congratulations to our 2013 award recipients and infinite thanks to our supporters for making this research funding possible.
Stanley Fahn Awards
The Stanley Fahn Award is presented to young investigators who conduct groundbreaking dystonia research with a focus on improved treatments. The DMRF established this award in honor of Stanley Fahn, MD of Columbia University who has made visionary and lasting contributions to the field of dystonia.
“Regulatory RNA Networks in Inherited Dystonia”
Pedro Gonzalez-Alegre, MD, University of Iowa
“D2 Dopamine Receptor Signaling Alteration in a Mouse Model of DYT1 Dystonia: A Novel Rescue Approach”
Antonio Pisani, MD, Fondazione Santa Lucia, University of Rome
Research Grants and Contracts
Research grants are available in support of hypothesis-driven research at the genetic, molecular, cellular, systems, or behavioral levels that may lead to a better understanding of the pathophysiology or to new therapies for any or all forms of dystonia. Contracts provide the opportunity to direct research through the identification of specific, milestone-driven projects to be conducted by identified investigators and closely monitored by the DMRF’s Chief Scientific Officer.
“Identification of Novel Drug Targets for DYT1 Dystonia”
BioFocus DPI, The Netherlands
“Comprehensive Examination of Motor Circuit Activity in Awake Behaving DYT1 Knockin Mice”
Nicole Calakos, MD, PhD, Duke University
“Assessing the Role of GNAL Pathway Genes in Primary Dystonia”
Tatiana Fuchs, PhD, Mount Sinai School of Medicine
“Morphological-Functional Analysis of the Endoplasmic Reticulum in a Mouse Model of DYT1 Dystonia”
N. Charles Harata, MD, PhD, University of Iowa
“Encoding of Interhemispheric Interactions in Mirror Dystonia: A Window to the Physiology of Dystonia”
Asha Kishore, MD, Sree Chitra Tirunal Institute for Medical Sciences and Technology, India
“Structural Characterization of Torsin1A with its Interactors at the Nuclear Envelope”
Thomas Schwartz, PhD, Massachusetts Institute of Technology
“Patient-specific Induced Pluripotent Stem (iPS) Cells as a Model for DYT1 Dystonia”
Nutan Sharma, MD, PhD and Cris Bragg, PhD, Massachusetts General Hospital
Research fellowships are designed to assist post-doctoral fellows establish careers in research relevant to dystonia.
“Identification of Genetic Causes of Dystonia in a Homogeneous Population”
Kristoffer Haugarvoll, PhD, Haukeland University Hospital, Norway
“Targeted and Genome Wide Analyses of Factors that Modify TorsinA∆E”
Lucia Zacchi, PhD, University of Pittsburgh
Accelerating Research & Inspiring Hope
The Dystonia Medical Research Foundation (DMRF) has served the dystonia community since 1976. Join us in our global effort to find a cure.